← Back to Patent Explorer
US4814175A Expired / Lapsed US ⏱️ 0.0 years remaining

Nifedipine combination preparation

Assignee: Bayer Pharma AG
•
Filing: 1987-03-18
•
Granted: 1989-03-21
•
Expires: 2007-03-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to nifedipine combination preparations, containing nifedipine with delayed release of active agent and a β-blocker in each case in granulated form, and their pharmaceutical usage as a therapeutic agent in cardiovascular diseases.

Inventors

  • 👤 Johannes-Wilhelm Tack
  • 👤 Manfred Albring
  • 👤 Fred Windt-Hanke

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 02:01
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5084; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 26 words
A gelatin capsule containing 1 part by weight of granulated nifidepine having a particle diameter of 10-50 μm and 0.01-0.5 parts by weight of granulated mepindolol.
Claim 2
Dependent Claim 26 words
A gelatin capsule containing 1 part by weight of granulated nifidepine having a particle diameter of 10-50 μm and 0.01-0.5 parts by weight of granulated mepindolol.
Claim 3
Dependent Claim 20 words
The capsule of claim 1 wherein both the granulated nifidepine and granulated mepindolol are coated before dispensing into the capsule.
Claim 4
Dependent Claim 14 words
The capsule of claim 1 further comprising auxiliary agents and excipients added before granulation.
Claim 5
Dependent Claim 21 words
Combination preparation according to claim 1, characterized in that the nifedipine component of the combination exhibits retarded release of active compound.
Claim 6
Dependent Claim 16 words
A process for treating cardiovascular disease which comprises the administration of the capsule of claim 1.
Claim 7
Dependent Claim 22 words
Combination preparation according to claim 1, characterized in that the granulated nifedipine and the granulated mepindolol are provided in one two-piece capsule.

References Cited (Backward Citations)

US4281654A Cited
GB2084017A Cited
US4510150A Cited
EP0142561A1 Cited
US4668770A Cited
US4690935A Cited
EP0165450A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-20 1992-09-19 1993-03-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-20 1996-09-19 1997-03-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-20 2000-09-19 2001-03-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag